[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356579-105":59,"doc-detail-356579-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","development-and-validation-of-a-predictive-model-combining-18f-fdg-petct-and-the-suidan-score-for-primary-optimal-cytoreduction-in-advanced-high-grade-serous-ovarian-cancer-a-retrospective-cohort-study","Development and Validation of a Predictive Model Combining [18F] FDG PET/CT and the Suidan Score for Primary Optimal Cytoreduction in Advanced High-Grade Serous Ovarian Cancer - A Retrospective Cohort Study","","Background: Advanced high-grade serous ovarian cancer patients undergoing cytoreductive surgery require reliable preoperative prediction of whether optimal cytoreduction can be achieved, to support adjuvant therapy and surveillance planning. Methods: A retrospective single-center cohort enrolled clinically staged IIIC–IVB HGSOC patients receiving primary cytoreductive surgery from Oct 2020 to Oct 2023, split into training and validation sets. Results: PET-CT radiomics outperformed the Suidan score, and the combined model achieved the highest discrimination with strong sensitivity, specificity, and predictive accuracy. Conclusion: The combined PET-CT radiomics-Suidan model enables accurate preoperative prediction of cytoreductive outcomes, guiding treatment strategy selection.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-and-validation-of-a-predictive-model-combining-18f-fdg-petct-and-the-suidan-score-for-primary-optimal-cytoreduction-in-advanced-high-grade-serous-ovarian-cancer-a-retrospective-cohort-study/356579/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-and-validation-of-a-predictive-model-combining-18f-fdg-petct-and-the-suidan-score-for-primary-optimal-cytoreduction-in-advanced-high-grade-serous-ovarian-cancer-a-retrospective-cohort-study/356579.png","ImageObject",300,407,{"name":92,"@type":93},"\tCallum ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main objective of this study?","Question",{"text":113,"@type":114},"To develop a preoperative PET-CT radiomics model and combine it with the Suidan score to predict optimal cytoreductive surgery outcomes in advanced high-grade serous ovarian cancer patients.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were patients selected and divided in the analysis?",{"text":118,"@type":114},"Patients with clinically staged IIIC–IVB high-grade serous ovarian carcinoma who underwent primary cytoreductive surgery between October 2020 and October 2023 were enrolled and split into training and validation cohorts.",{"name":120,"@type":111,"acceptedAnswer":121},"Which model performed best in validation?",{"text":122,"@type":114},"The combined model (PET-CT radiomics plus the Suidan score) achieved the highest predictive performance in validation, with AUC 0.836 and an accuracy of 83.3%.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},356579,1790190777,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},137451211410,"https://ap-avatar.wpscdn.com/avatar/2000bb0a9246f588df?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786362646172706240","DATABASE ANALYSIS  \ne-ISSN 1643-3750  \n© Med Sci Monit, 2026; 32: e951183 DOI: 10. 12659/MSM.951183  \nReceived: 2025.08.19  \nAccepted: 2026.01.20  \nAvailable online: 2026.02.04  \nPublished: 2026.03.31  \nAuthors’ Contribution: Study Design A  \nData Collection B Statistical Analysis C Data Interpretation D Manuscript Preparation E Literature Search F Funds Collection G  \nACE  \nCD  \nBC  \nDE  \nEF  \nEF  \nAFG  \nCorresponding Author: Financial support:  \nConflict of interest:  \n1 2  \n1 1  \n1 1  \n1  \nDevelopment and Validation of a Predictive Model Combining [18F] FDG PET/CT  \nand the Suidan Score for Primary Optimal Cytoreduction in Advanced High-Grade Serous Ovarian Cancer: A Retrospective Cohort Study  \nXiaohang Lu*  \nXiaomei Wang* Shengnan Wang* Jiazhen Huang Wei Wei  \nFuli Kang Ning Wang  \n1 Department of Gynaecology, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, PR China  \n2 Department of Nuclear Medicine, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, PR China  \n* Xiaohang Lu, Xiaomei Wang and Shengnan Wang contributed equally to this work and share first authorship  \nNing Wang, e-mail: [nona-ware@dmu.edu.cn](nona-ware@dmu.edu.cn)  \nThis work was supported by grants from the “1+X” Foundation of the Second Hospital of Dalian Medical University (Grant No. 81572579, No. 81660430)  \nNone declared  \nBackground: For patients with advanced ovarian cancer undergoing cytoreductive surgery, achieving optimal surgical outcomes has significant clinical implications for the design of adjuvant therapy and surveillance strategies. This retrospective, single-center cohort study aimed to develop a radiomics model based on preoperative PET-CT imaging parameters to predict optimal cytoreductive surgery outcomes, thereby providing clinical decision-making support to improve the prognosis of patients with advanced ovarian cancer.  \nMaterial/Methods: Patients with clinically staged IIIC-IVB high-grade serous ovarian carcinoma (HGSOC) who underwent primary cytoreductive surgery between October 2020 and October 2023 were enrolled and divided into training and validation cohorts. A radiomics model based on preoperative PET-CT was developed, and its performance was quantitatively evaluated and compared within the validation cohort. Subsequently, the PET-CT radiomics model was combined with the Suidan score to generate a combined model.  \nResults: Optimal cytoreduction rates were 72.86%(training) and 75.0%(validation). The PET-CT radiomics model demonstrated superior discriminative ability (AUC: 0.808, 95%CI: 0.665-0.951) compared to the Suidan score (AUC:  \n0.773, 95%CI: 0.615-0.931) in validation. The combined model achieved the highest predictive performance (AUC: 0.836, 95%CI: 0.706-0.966), with sensitivity 81.8%, specificity 83.9%, PPV 64.3%, NPV 92.9%, and accuracy 83.3%.  \nConclusions: The combined model integrating PET-CT radiomics and Suidan score provides accurate preoperative prediction of cytoreductive outcomes, optimizing treatment strategies for advanced ovarian cancer.  \nKeywords: Fluorodeoxyglucose F18 • Cytoreduction Surgical Procedures • Ovarian Neoplasms •  \nPositron-Emission Tomography  \nFull-text PDF: [https://www.medscimonit.com/abstract/index/idArt/951183](https://www.medscimonit.com/abstract/index/idArt/951183)  \n3579  2  5  38  \nPublisher’s note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher  \nThis work is licensed under Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)  \ne951183-1  \nIndexed in: [Current Contents/Clinical Medicine] [SCI Expanded] [ISI Alerting System][ISI Journals Master List] [Index Medicus/MEDLINE] [EMBASE/Excer","cbCaibEO3B5v5TBI","https://ap.wps.com/l/cbCaibEO3B5v5TBI","pdf",1368426,11,"English","# Background\n# Material/Methods\n## Study design and cohorts\n## Model development and comparison\n# Results\n# Conclusions","[{\"question\":\"What was the main objective of this study?\",\"answer\":\"To develop a preoperative PET-CT radiomics model and combine it with the Suidan score to predict optimal cytoreductive surgery outcomes in advanced high-grade serous ovarian cancer patients.\"},{\"question\":\"How were patients selected and divided in the analysis?\",\"answer\":\"Patients with clinically staged IIIC–IVB high-grade serous ovarian carcinoma who underwent primary cytoreductive surgery between October 2020 and October 2023 were enrolled and split into training and validation cohorts.\"},{\"question\":\"Which model performed best in validation?\",\"answer\":\"The combined model (PET-CT radiomics plus the Suidan score) achieved the highest predictive performance in validation, with AUC 0.836 and an accuracy of 83.3%.\"}]","Development and Validation of a Predictive Model Combining [18F] FDG PET/CT and the Suidan Score for Primary Optimal Cytoreduction in Advanced High-Grade Serous Ovarian Cancer - A Retrospective Cohort Study | PDF",1790126041,28,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f4c7d3011721f630cbee2347b317c53.webp",983,1376,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4d5ebe8779be9ee3b1d488feb91e9b6.webp",982,1374,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cac5596c8a1b45dc569f683a1267c2a3.webp",981,1373,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1d2d2be2002216d912a7eb23403f860.webp",980,1372]